CIPROX IV
Unparallel from its release
17 years History of Ciprofloxacin IV Formulation -
Intravenous formulation was introduced in 1991
Extremely studied and documented in over 37000 publications
More than 100000 patients enrolled in double blind trials around the world
Prescribed for more than 340 million patients worldwide
Available in more than 100 countries and has been approved for the treatment of 14 categories of infections Especially - UTIs & Nosocomial Infections
Extensive and unprecedented safety profile
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment